GlassScriptPhysician profile
Jonathan Eric Mennucci
NPI 1871946525
$1,786.17
in general payments reported to CMS, 2019-2025
14 companies · $585 in 2025
The $585 reported for 2025 was more than what 81% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $266 · 2020: $146 · 2021: $143 · 2022: $225 · 2023: $206 · 2024: $215 · 2025: $585.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,006.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,006.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $750.10 | 2019-2025 | |
| Alcon Vision LLC | $288.29 | 2022-2025 | Clareon, Precision 1, Rocklatan |
| Tarsus Pharmaceuticals, INC. | $176.90 | 2024-2025 | Xdemvy |
| Johnson & Johnson Vision Care, INC. | $117.55 | 2019 | |
| Tearlab Corp | $106.86 | 2019 | |
| Allergan, INC. | $87.03 | 2020 | |
| Abbvie INC. | $54.62 | 2024-2025 | |
| Sun Pharmaceutical Industries INC. | $40.40 | 2019-2023 | Cequa |
| Sight Sciences, INC. | $40.29 | 2024 | Omni Surgical System |
| Dompe US, INC. | $36.91 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $30.99 | 2023 | |
| Amgen INC. | $26.89 | 2025 | Tepezza |
| Thea Pharma INC. | $18.40 | 2025 | Iyuzeh |
| Shire North American Group INC | $10.94 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Mennucci listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.